Login
Subscribe
PLOS ONE Pulls Five Papers Tied to Alzheimer’s Drug Controversy
PLOS ONE Pulls Five Papers Tied to Alzheimer’s Drug Controversy
The retracted studies were coauthored by a scientist who worked on an Alzheimer’s therapy in development by Cassava Sciences, a company reportedly under investigation for providing falsified data to the FDA.
The retracted studies were coauthored by a scientist who worked on an Alzheimer’s therapy in development by Cassava Sciences, a company reportedly under investigation for providing falsified data to the FDA.
Securities and Exchange Commission
SEC Charges uBiome Founders with Defrauding Investors
Catherine Offord | Mar 23, 2021 | 2 min read
The microbiome-testing company made misleading claims about its prospects and about its business strategy, which allegedly relied on fooling doctors into ordering unnecessary tests, according to the US government.
“Co-op” Lets Users Barter DNA and Health Information for Shares
Shawna Williams | Dec 7, 2018 | 2 min read
LunaDNA receives Securities and Exchange Commission approval to treat the data as currency.
Theranos Goes Under
Sukanya Charuchandra | Sep 5, 2018 | 1 min read
The discredited blood-testing company announced its decision to close in a company-wide email.
SEC Charges Theranos With Fraud
Jim Daley | Mar 14, 2018 | 2 min read
The company raised more than $700 million based on false claims to investors, according to the complaint.